| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |